Company: Takeda Pharmaceutical Company Limited (TAK)
*DRIP Club Members are able to acquire or list a share of a company on the DRIP Exchange Page.
Company Profile: Takeda Pharmaceutical is JapanÕs largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The companyÕs five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada. -Morningstar.com-
Symbol: TAK
Recent Price: $13.37
Dividends: $0.64
Yield: 4.79%
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Address & Company Phone #: 1-1 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8668 Japan, 81 3 3278 2111
Transfer Agent: Computershare 877-337-1575
Moody’s Rating: Baa2
Minimum & Maximum Investment: $50 – $100,000/year
Investment Dates: Weekly
Shares to Qualify: 1 Share or $200
Fees: Div.: 5% of amount invested up to $5 Max Cash: $5+10¢/sh. Cert: Sells: by Mail, Phone or Internet for $25+12¢/sh.
52 Week High & Low: $17.15, $13.19